Xeno Transplants Corporation

OTCPK:XENO Stock Report

Market Cap: US$4.0k

Xeno Transplants Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Elliot Lebowitz

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure18.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure17.1yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Elliot Lebowitz (81 yo)

18.3yrs

Tenure

Dr. Elliot Lebowitz, Ph.D. has been President and Chief Executive Officer of Xeno Transplants Corporation since August 2, 2006. Dr. Lebowitz also has been President and Chief Executive Officer of Xeno sinc...


Board Members

NamePositionTenureCompensationOwnership
Wayne Smith
Chief Financial Officer17.3yrsUS$20.96kno data
Elliot Lebowitz
Chief Executive Officer18.3yrsno datano data
Milton Datsopoulos
Directorno datano datano data
Michael Perry
Chairman17yrsno datano data
David Sachs
Director17yrsno datano data

17.1yrs

Average Tenure

81yo

Average Age

Experienced Board: XENO's board of directors are seasoned and experienced ( 17.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.